FTO negatively regulates the cytotoxic activity of natural killer cells

EMBO Rep. 2023 Apr 5;24(4):e55681. doi: 10.15252/embr.202255681. Epub 2023 Feb 6.

Abstract

N6 -Methyladenosine (m6 A) is the most abundant epitranscriptomic mark and plays a fundamental role in almost every aspect of mRNA metabolism. Although m6 A writers and readers have been widely studied, the roles of m6 A erasers are not well-understood. Here, we investigate the role of FTO, one of the m6 A erasers, in natural killer (NK) cell immunity. We observe that FTO-deficient NK cells are hyperactivated. Fto knockout (Fto-/- ) mouse NK cells prevent melanoma metastasis in vivo, and FTO-deficient human NK cells enhance the antitumor response against leukemia in vitro. We find that FTO negatively regulates IL-2/15-driven JAK/STAT signaling by increasing the mRNA stability of suppressor of cytokine signaling protein (SOCS) family genes. Our results suggest that FTO is an essential modulator of NK cell immunity, providing a new immunotherapeutic strategy for allogeneic NK cell therapies.

Keywords: FTO; N6-methyladenosine; NK cell; epitranscriptome; m6A regulator.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alpha-Ketoglutarate-Dependent Dioxygenase FTO / genetics
  • Animals
  • Antineoplastic Agents*
  • Cytokines
  • Humans
  • Killer Cells, Natural*
  • Mice
  • Signal Transduction

Substances

  • Antineoplastic Agents
  • Cytokines
  • FTO protein, human
  • Alpha-Ketoglutarate-Dependent Dioxygenase FTO
  • FTO protein, mouse